<img alt="" height="1" width="1" />
Baxter Alzheimer's treatment shows early promise
Reuters
CHICAGO, April 13 (Reuters) - Alzheimer's disease patients treated with Baxter International's (BAX.N) Gammagard for 18 months showed better cognitive function and less brain enlargement than those given a placebo, the company said on Tuesday. ...
Baxter drug shows promise in Alzheimer'sMarketWatch
Baxter Drug Helps Alzheimer's Patients Maintain BrainBusinessWeek
Baxter's Alzheimer Drug Show Encouraging Results In Phase II Study - UpdateRTT News
MarketWatch (press release) -MSN Money -Chicago Breaking Business - Tribune
all 29 news articles »
More...